Volya

Übungen bei Gliedergürtel-Muskeldystrophie (LGMD) — 30+ Subtypen, subtypabhängige kardiale/respiratorische Überwachung, moderate Aerobic + leichte Kraft SICHER

LGMD — 30+ Subtypen mit unterschiedlichen Kardiorisiken. Genetische Bestätigung OBLIGATORISCH. Moderate Aerobic + leichte Kraft SICHER.

Keine medizinische Beratung

Diese Seite ist informativ. Volya ist kein Medizinprodukt und diagnostiziert, behandelt, verhindert oder heilt keine Erkrankung. Bei chronischen Erkrankungen, Schwangerschaft, postoperativ oder unter Medikation sprich vor Diät-/Trainingsänderung mit deinem Arzt.

Narayanaswami 2014 AAN/ANEM + Straub 2018 + LGMD Awareness Foundation + Mercuri 2019. Limb-girdle muscular dystrophy is not one disease but a heterogeneous group of 30+ genetic subtypes, differing dramatically in cardiac risk, respiratory risk, age of onset, and prognosis. Major split: autosomal recessive (LGMD2/R, most common globally) vs autosomal dominant (LGMD1/D). The most common AR subtypes include LGMD2A (calpainopathy, most common globally, typically cardiac-spared), LGMD2B (dysferlinopathy, very late-onset, distal involvement, exercise-triggered acute rhabdomyolysis caution), LGMD2C-2F (sarcoglycanopathies, CHILDHOOD onset DMD-like, HIGH cardiac risk), LGMD2I (FKRP, variable severity, cardiac + respiratory risk). The most common AD subtypes include LGMD1B (LMNA laminopathy — VERY HIGH arrhythmia + sudden cardiac death risk, ICD threshold lowered per Anselme 2008). GENETIC CONFIRMATION IS MANDATORY — without it cardiac surveillance plan is guesswork. Cardiac risk subtypes need annual echo + ECG + Holter from diagnosis; LGMD1B/LMNA needs surveillance starting BEFORE skeletal symptoms because sudden death may precede weakness. Respiratory: LGMD2I + LGMD2A + others may develop respiratory failure later; spirometry baseline + serial. Exercise per Olsen 2005 + van der Kooi 2007 + Sveen 2007: moderate aerobic + light strength IS safe and IMPROVES function across LGMD subtypes; AVOID exhaustion + AVOID eccentric peak loading; LGMD2B (dysferlinopathy) specifically — AVOID maximal exertion (rhabdomyolysis risk).

Volya's catalogue carries the foundation moves: supported-glute-bridge for posterior chain low-intensity (proximal pelvic-girdle weakness is the LGMD presentation), wall-push-up for upper-body push at low load (shoulder-girdle weakness common), scapular-retraction for upper-back posture + scapular stabilisation, cat-cow for spinal mobility, supine-knee-to-chest for low-back release + hip flexor stretch, diaphragmatic-breathing for respiratory training (subtype-specific need), seated-march for cardio without joint impact, ankle-pump for circulation + distal ROM + DVT prevention, sit-to-stand for functional + bone-loading within ability + balance. The AI coach also knows the nutrition side — protein 1.2-1.5 g/kg + leucine 2.5-3 g per meal anabolic threshold, cardiac-protective Mediterranean + omega-3 + low-sodium for at-risk subtypes (LGMD1B/LMNA + 2C-F sarcoglycanopathies + 2I FKRP), Ca + vit D + weight-bearing + DEXA for bone, individualised caloric per subtype + mobility status, AVOID ultra-processed + alcohol excess (cardiac), creatine 3-5 g/day modest benefit (Walter 2002 + Tarnopolsky 2004), consider CoQ10 100-200 mg if statin-prescribed (mitochondrial component). CRITICAL: LGMD Awareness Foundation + Coalition to Cure Calpain 3 (LGMD2A) + Jain Foundation (LGMD2B/dysferlinopathy) + Sarcoglycanopathy CARE + Speak Foundation (LGMD2I) + Cure CMD + MDA + neurology (LGMD-experienced) + GENETIC CONFIRMATION + cardiology (subtype-specific from diagnosis if at-risk) + pulmonology if respiratory subtype + PT/OT + dietitian + family genetic counselling. This is NEVER a replacement for LGMD-experienced multidisciplinary care.

Related

Try it now

LGMD — 30+ Subtypen mit unterschiedlichen Kardiorisiken. Genetische Bestätigung OBLIGATORISCH. Moderate Aerobic + leichte Kraft SICHER.

LGMD-Katalog